Shark cartilage of no use in advanced cancer

	Tweet

Treatment with a shark cartilage product does not prolong life in patients with advanced cancer, nor does it improve quality of life, U.S. researchers reported in the journal Cancer.

Shark cartilage has become a popular alternative medicine for people with advanced cancer. Its use is based on the belief that the reason sharks rarely develop cancer is because of their high cartilage content. Previous reports examining the benefits of shark cartilage as an anti-cancer therapy, however, have yielded mixed results.

In one of the few randomized trials to evaluate this treatment, Dr. Charles L. Loprinzi, from the Mayo Clinic in Rochester, Minnesota, and colleagues compared the outcomes of 89 patients with incurable breast or Colon cancer who were treated with shark cartilage or placebo in addition to standard care and treatment with chemotherapy if appropriate.

The shark cartilage and placebo were supplied as a powder, mixed with water or juice, and consumed three to four times per day.

There was no difference in overall survival between subjects drinking shark cartilage and those drinking placebo, the researchers report in the journal Cancer.

Moreover, there was no evidence that cartilage-treated patients experienced a better quality of life than placebo-treated patients. And only cartilage-treated subjects reported diarrhea, breathing difficulties, low white blood cell count and bone pain.

“There is no evidence to suggest a survival benefit from shark cartilage based on our data,” the investigators conclude. However, it is possible that in the future there may be a drug derived from shark cartilage that has a role in cancer therapy, they add.

SOURCE: Cancer July 1, 2005.

RELATED STORIES:
New drug slows advanced kidney cancer   Study may provide new hope for cancer patients   Cancer Gene Drives Pivotal Decision in Early Brain Development   Low testosterone a problem in cancer: study   Nanoparticles + Light = Dead Tumor Cells   Exercise can reduce cancer treatment side effects   Some tumors contain factors that may block metastasis   Scientists may be able to double efficacy of radiation therapy   Study links infections with some childhood cancers   Vitamin D deficiency common in cancer patients   Smart bomb drug zaps cancer cells in mice   Improving Cancer Diagnosis   Cancer Therapy: A Role for MAPK Inhibitors Combined with mTORC1 Inhibitors   New study widens cancer risks and benefits of pill   Scientists devise targeted therapy strategy for rare form of childhood cancer   Nanocenter Offers Promising Non-Invasive Cancer Treatment   New Combination Therapy that Promotes Cancer Cell Death   New Cancer Gene Discovered   Patients Need Help Finding Medical Information   New process that can save at-risk cancer patients is effective and significantly less costly   Gene Therapy, Cancer-Killing Viruses and New Drugs Highlight Novel Approaches to Cancer Treatment   Drug Therapy to Bolster Immune System Cells Found Effective Toward Childhood Cancer

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]